Form 8-K - Current report:
SEC Accession No. 0001654954-17-005826
Filing Date
2017-06-23
Accepted
2017-06-23 12:29:42
Documents
3
Period of Report
2017-06-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sbfm_8k.htm 8-K 27482
2 PRESS RELEASE sbfm_ex996.htm EX-99.6 10999
3 IMAGE logo.jpg GRAPHIC 10894
  Complete submission text file 0001654954-17-005826.txt   54971
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52898 | Film No.: 17926975
SIC: 8731 Services-Commercial Physical & Biological Research